Back to Search
LAURA HAVRILESKY, MD
MD
Gynecologic Oncology Physician
NPI: 1316971526IndividualAccepts Medicare
Specialties, Licenses & Credentials
Gynecologic Oncology PhysicianPrimary
Obstetrics & Gynecology — Gynecologic Oncology
Code: 207VX0201X
Education
DUKE UNIVERSITY SCHOOL OF MEDICINE
Class of 1995
Research & Publications (20)
Cost effectiveness of a test to detect metastases for endometrial cancer.
PMID 19100608·Gynecol Oncol·2009
8-other
Determination of quality of life-related utilities for health states relevant to ovarian cancer diagnosis and treatment.
PMID 19217148·Gynecol Oncol·2009
8-other
Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer.
PMID 19446319·Gynecol Oncol·2009
4-observational
Cost-effectiveness analysis of annual screening strategies for endometrial cancer.
PMID 19380121·Am J Obstet Gynecol·2009
8-other
Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence.
PMID 18584856·Gynecol Oncol·2008
8-other
Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?
PMID 18722004·Gynecol Oncol·2008
8-other
Cost effectiveness of intraperitoneal compared with intravenous chemotherapy for women with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study.
PMID 18757328·J Clin Oncol·2008
8-other
Outcomes in surgical stage I uterine papillary serous carcinoma.
PMID 17355889·Gynecol Oncol·2007
4-observational
Management of platinum-sensitive recurrent ovarian cancer: a cost-effectiveness analysis.
PMID 17870150·Gynecol Oncol·2007
4-observational
The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer.
PMID 17014898·Gynecol Oncol·2007
8-other
Resection of lymph node metastases influences survival in stage IIIC endometrial cancer.
PMID 16126261·Gynecol Oncol·2005
8-other
Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer.
PMID 15099957·Gynecol Oncol·2004
4-observational
Predictors of clinical outcomes in the laparoscopic management of adnexal masses.
PMID 12907095·Obstet Gynecol·2003
5-case
The role of PET scanning in the detection of recurrent cervical cancer.
PMID 12821362·Gynecol Oncol·2003
4-observational
Prognostic significance of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer: a Gynecologic Oncology Group Study.
PMID 14551300·J Clin Oncol·2003
8-other
Weekly low-dose carboplatin and paclitaxel in the treatment of recurrent ovarian and peritoneal cancer.
PMID 12504627·Gynecol Oncol·2003
3-trial
Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations.
PMID 11733961·Gynecol Oncol·2001
8-other
A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
PMID 19560193·Gynecol Oncol·2009
4-observational
Evaluation of two management strategies for preoperative grade 1 endometrial cancer.
PMID 19546752·Obstet Gynecol·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1000 TRENT DRIVE
DURHAM, NC 27710 - Phone
- (919) 684-8111
Quick Facts
- NPI
- 1316971526
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 31
- Publications
- 20
Are you this provider?
Claim Your Profile